Oragenics, Inc.OGENNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-36.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -127.07% |
| Q2 2025 | 37.77% |
| Q1 2025 | -4.64% |
| Q4 2024 | -2.44% |
| Q3 2024 | -27.56% |
| Q2 2024 | 49.60% |
| Q1 2024 | -177.93% |
| Q4 2023 | 26.64% |
| Q3 2023 | 41.67% |
| Q2 2023 | -22.19% |
| Q1 2023 | 13.32% |
| Q4 2022 | 35.57% |
| Q3 2022 | -11.62% |
| Q2 2022 | 39.99% |
| Q1 2022 | -199.13% |
| Q4 2021 | 58.85% |
| Q3 2021 | -120.36% |
| Q2 2021 | 51.97% |
| Q1 2021 | -19.16% |
| Q4 2020 | 22.16% |
| Q3 2020 | 3.46% |
| Q2 2020 | -26.42% |
| Q1 2020 | 2.89% |
| Q4 2019 | -16.54% |
| Q3 2019 | 3.16% |
| Q2 2019 | -57.78% |
| Q1 2019 | 25.76% |
| Q4 2018 | -21.33% |
| Q3 2018 | -7.61% |
| Q2 2018 | -66.89% |
| Q1 2018 | -0.58% |
| Q4 2017 | -1.44% |
| Q3 2017 | 24.11% |
| Q2 2017 | 7.13% |
| Q1 2017 | 3.24% |
| Q4 2016 | -17.40% |
| Q3 2016 | 4.75% |
| Q2 2016 | -4.43% |
| Q1 2016 | -4.51% |
| Q4 2015 | -27.40% |